SCHEMBL3515909

SCHEMBL3515909

CCOC(=O)c1c(O)c2c(Cc3cccc(-c4cccc(CN)c4)c3)ccnc2n(O)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
PDE3B Q13370 4/20 0.36
PDE3A Q14432 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALOX5 P09917 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 1/20 0.35
PTGES O14684 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
CFD P00746 3/20 0.34
PLAU P00749 2/20 0.33
PLG P00747 1/20 0.33
F11 P03951 1/20 0.33
KLKB1 P03952 1/20 0.33
F7 P08709 1/20 0.33
TPSB2 P20231 1/20 0.33
RECQL P46063 1/20 0.33
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13435325 0.78 IDH1 (0.39) CFDPLAUPLGF11KLKB1
SCHEMBL3515919 0.78 KIT (0.38) MAPTMAPK1KDM4EALDH1A1GAA
SCHEMBL3516138 0.76 KDM4E (0.46) MAPTSMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL3515889 0.75 NPC1 (0.48) MAPTMAPK1SMN1; SMN2ALOX5KDM4E
SCHEMBL3516284 0.74 PDE3B (0.43) MAPTMAPK1PDE3BPDE3ASMN1; SMN2
SCHEMBL3514511 0.74 BRD4 (0.38) MAPTMAPK1KDM4EALDH1A1GAA
SCHEMBL19509569 0.70 CNR1 (0.30)
SCHEMBL3514518 0.69 MAOB (0.41) MAPTSMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL3514525 0.69 ALDH1A1 (0.55) SMN1; SMN2KDM4EALDH1A1GAARECQL
SCHEMBL3518359 0.68 KDM4E (0.48) MAPTSMN1; SMN2KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
EP-2044068-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS Merck & Co., Inc. (US) 2009-04-08 EP disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL MAPT 3237/4885MAPK1 1239/4885PDE3B 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.